Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-14-011789
Filing Date
2014-06-24
Accepted
2014-06-24 17:10:07
Documents
1
Period of Report
2014-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 JUNE 20, 2014 rdgdoc.html 4  
1 FORM 4 JUNE 20, 2014 rdgdoc.xml 4 3786
  Complete submission text file 0001437749-14-011789.txt   5370
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MOLECULAR INSIGHT PHARMACEUTICALS, INC. 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
Borys Nicholas (Reporting) CIK: 0001388138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 14938107